Novartis gender discrimination trial wrapping up; Pharma ups online marketing;

  @FiercePharma: Pfizer to sell NY building, cut up to 1,400 jobs. Report | Follow @FiercePharma

> The system for determining pay and promotions at Novartis' U.S. unit is "broken beyond repair" and allows a pattern and practice of discrimination against its female employees, a lawyer for the women suing the company said in closing arguments Tuesday. Report

> Pharma brands quickened their shift toward online consumer media last year but continued to invest more in web-based professional outreach, new data show. Report

> Genzyme said it is looking into stockowner allegations that some company officials sold Genzyme shares based on information that wasn't available to all investors. Report

> Germany's Stada Arzneimittel posted slightly lower quarterly earnings than analysts had expected as it continued to scramble for generic-drug bulk contracts in its home market. Report

> Cadila Healthcare said it has received approval from the Drugs Controller General of India to market its H1N1 vaccine in the country. Report

> Biotech company Gilead Sciences, whose share price has stagnated this year following drug development setbacks, said it plans to buy back up to $5 billion of its shares through May 2013. Report

Biotech News

 @FierceBiotech:Mayo team discovers new diabetes drug class. Article | Follow @FierceBiotech

 @JohnCFierce: Merck is making a case today for its post-merger approval prospects. 5 new apps this year, 20 drugs in late stage.  Report | Follow @JohnCFierce

> Mesoblast to acquire Angioblast and speed up stem cell work. Story

> Troubled Genzyme launches probe into insider trading claims. News

> Is the market for biotech start-ups coming back to life? Report

> Optimer names Pedro Lichtinger president, CEO. Article

Drug Delivery News

> Inhalable measles vax holds promise for other diseases. Article

> Pain tablet has sustained-release pharmacokinetic profile. Report

> FDA approves Duplex system for Cefepime delivery. News

> Soligenix gets oral, topical GI steroids patent. Article

> Quest doses first prostate cancer patient with photodynamic therapy. Report

Medical Device News

> Report: Covidien looks to expand. Article

> FDA: St. Jude illegally promoted ablation device. Story

> CardioMEMS raises $37.9M in financing. Report

> Medtronic, St. Jude unveil wireless monitoring devices. News

> Teleflex recalls humidifier. Report

And Finally... Serial whistleblowers split a $45 million award after AstraZeneca settled Seroquel marketing claims. Report

Suggested Articles

After years of having first-line liver cancer market to itself, Bayer’s Nexavar is getting major competition from Roche's Tecentriq.

Most of the recent enthusiasm around AbbVie’s new drugs has centered on Skyrizi and Rinvoq, but elagolix wants a piece of the spotlight, too.

During David Loew's tenure, Sanofi Pasteur bought Protein Sciences, whose recombinant technology is being applied to a COVID-19 vaccine.